Hedge Fund - Steelhead Partners
Alnylam Pharmaceuticals Inc. (ALNY) NOTE 1.000% 9/1
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q2 (2025-06-30) | $84,641,050 | 4.26% | 65,000,000 | $276.71 |
| 2 | 2025 - Q1 (2025-03-31) | $49,632,535 | 2.86% | 43,000,000 | $257.00 |
| 3 | 2024 - Q4 (2024-12-31) | $6,940,733 | 0.34% | 6,500,000 | $262.99 |
| 4 | 2024 - Q3 (2024-09-30) | $0 | 0% | 0 | $260.36 |
| 5 | 2024 - Q2 (2024-06-30) | $28,569,518 | 1.48% | 26,500,000 | $157.87 |
| 6 | 2024 - Q1 (2024-03-31) | $32,865,350 | 1.72% | 35,000,000 | $166.82 |
| 7 | 2023 - Q4 (2023-12-31) | $54,514,900 | 2.82% | 55,000,000 | $170.34 |
| 8 | 2023 - Q3 (2023-09-30) | $51,119,475 | 2.99% | 55,000,000 | $191.12 |
The displayed share prices are average quarterly stock market prices.